跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
HANLIM HEPARIN SODIUM INJECTION 25,000 IU/5 ML - HSA Drug Approval Details
Approvals
/
HSA
/
HANLIM HEPARIN SODIUM INJECTION 25,000 IU/5 ML
Approved
THERAPEUTIC
HANLIM HEPARIN SODIUM INJECTION 25,000 IU/5 ML
HANLIM PHARMACEUTICAL CO LTD (KOREA, REPUBLIC OF)
🇸🇬 Health Sciences Authority
Approval Date
Jul 20, 1999
Approval ID
d264d8c3552ea73a
Company
HANLIM PHARMACEUTICAL CO LTD (KOREA, REPUBLIC OF)
Type
Therapeutic
Approval Details
Approval Id
d264d8c3552ea73a
Drug Name
HANLIM HEPARIN SODIUM INJECTION 25,000 IU/5 ML
Product Name
HANLIM HEPARIN SODIUM INJECTION 25,000 IU/5 ML
Approval Number
SIN11035P
Approval Date
1999-07-20
Registrant
PHARMAFORTE SINGAPORE PTE LTD
Licence Holder
PHARMAFORTE SINGAPORE PTE LTD
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
INJECTION
Route Of Administration
INTRAVENOUS, SUBCUTANEOUS
Atc Code
B01AB01
Atc Item Name
heparin
Pharma Manufacturer Name
PHARMAFORTE SINGAPORE PTE LTD
Active Ingredients
HEPARIN SODIUM
25000 iu/5 ml
HEPARIN SODIUM
25000 iu/5 ml
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jul 20, 1999
Approval ID
d264d8c3552ea73a
Type
Therapeutic
Back to HSA Approvals
